Welcome to Mehta Partners

With more than 2 decades of diverse experience & integrated perspectives on the BioPharma industry worldwide, our enduring commitment to our clients sets us apart.

We invite you to contact us to schedule a meeting or conference call.


 Viren Mehta


Trump says the biopharma industry can no longer depend on the higher US profit margins with his initiative to peg US drug prices to global norms. The US president needs second and third initiatives to be successful: Enable the regulators and biopharma industry to rationalize R&D, and to eliminate selling costs that collectively account for one-half of the industry, writes Viren Mehta, founding partner of Mehta Partners LLC.

" ... Read more

7 Nov 2018 | From the latest Perspectives entry by Viren Mehta, Mehta Analysis: Can Trump Trigger Triple Cascade?